亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。
Discovery of Novel Inhibitors of the FKBP51 Protein from a High-throughput Drug Screen
技術優勢
First treatment to target FKBP51, All FDA approved compounds, Can be immediately implemented
詳細技術說明
Through the use of high-throughput screening University of South Florida researchers have identified several compounds with strong inhibitory activity against FKBP51, which could potentially be immediately implemented into clinics to treat specific patient populations with high levels of FKBP51. These drugs are all FDA approved and could be prescribed off label for the purpose of reducing FKBP51 levels. Patients with elevated levels of FKBP51, specifically those with SNPs in the FKBP5 gene or aged/AD patients, could immediately benefit from receiving drugs that target inhibition of FKBP51.
國家/地區
美國
欲了解更多信息，請點擊 這裡
